Cerevance has said it plans to move on to late-stage trials of its first-in-class Parkinson's disease drug CVN424 after hitting the mark in a phase 2 proof-of-concept study. The Boston-based biotech ...
Money Talks News on MSN
Work-from-home jobs with 6-figure salaries
You might be surprised by some of the jobs you can do from home.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results